Chemoinformaics analysis of N-P-COUMARYL-GLUTAMIC-ACID
| Molecular Weight | 279.292 | nRot | 8 |
| Heavy Atom Molecular Weight | 262.156 | nRig | 9 |
| Exact Molecular Weight | 279.111 | nRing | 1 |
| Solubility: LogS | -1.929 | nHRing | 0 |
| Solubility: LogP | -1.671 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 39.8255 |
| nHD | 4 | BPOL | 19.3605 |
| QED | 0.571 |
| Synth | 2.694 |
| Natural Product Likeliness | 0.79 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.073 |
| CACO-2 | -6.014 |
| MDCK | 0.00000669 |
| BBB | 0.123 |
| PPB | 0.590915 |
| VDSS | 0.444 |
| FU | 0.545912 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.032 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.82 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.006 |
| CL | 5.039 |
| T12 | 0.879 |
| hERG | 0.027 |
| Ames | 0.004 |
| ROA | 0.069 |
| SkinSen | 0.538 |
| Carcinogencity | 0.129 |
| EI | 0.051 |
| Respiratory | 0.261 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.816935 |